Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ENIGMACHEK2gether Project: A Comprehensive Study Identifies Functionally ImpairedCHEK2Germline Missense Variants Associated with Increased Breast Cancer Risk
Lenka Stolařová, Petra Kleiblová, Petra Zemánková, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3037-3050
Open Access | Times Cited: 18

Showing 18 citing articles:

ZNF703 promotes Triple-Negative breast cancer cell progression and in combination with STK11 predicts disease recurrence (ZS −TNBC Model)
Gen Wang, Jialiang Wang, Zesong Li, et al.
Gene (2025) Vol. 942, pp. 149258-149258
Closed Access
Protein-truncating and rare missense variants inATMandCHEK2and associations with cancer in UK Biobank whole-exome sequence data
Toqir K Mukhtar, Naomi Wilcox, Joe Dennis, et al.
Journal of Medical Genetics (2024), pp. jmg-110127
Open Access | Times Cited: 4
A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition
Petra Zemánková, Marta Černá, Klara Horáčková, et al.
The Breast (2024) Vol. 75, pp. 103721-103721
Open Access | Times Cited: 3
Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer‐rich regions and 38 spliceogenic variants
Lara Sanoguera‐Miralles, Inés Llinares‐Burguet, Elena Bueno‐Martínez, et al.
The Journal of Pathology (2024) Vol. 262, Iss. 4, pp. 395-409
Open Access | Times Cited: 2
Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas
Sunita M. C. De Sousa, Ann McCormack, Andreas Orsmond, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 2
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Pavlina Chrysafi, Chinmay Jani, Margaret Lotz, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5762-5762
Open Access | Times Cited: 5
Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2
Claire E. McCarthy, George S. Brush, Roger Piqué-Regi, et al.
PLoS Genetics (2024) Vol. 20, Iss. 8, pp. e1011375-e1011375
Open Access | Times Cited: 1
Increased Frequency of CHEK2 Germline Pathogenic Variants Among Individuals with Dermatofibrosarcoma Protuberans
Michael R. Sargen, Jung Kim, Jeremy S. Haley, et al.
Genetics in Medicine Open (2024) Vol. 2, pp. 101895-101895
Open Access | Times Cited: 1
Germline Variant Spectrum in Southern Italian High-Risk Hereditary Breast Cancer Patients: Insights from Multi-Gene Panel Testing
Valentina Rocca, Elisa Lo Feudo, Francesca Dinatolo, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 13003-13020
Open Access | Times Cited: 1
A missense variant effect map for the human tumor-suppressor protein CHK2
Marinella Gebbia, Daniel S. Zimmerman, Rosanna Jiang, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 12, pp. 2675-2692
Closed Access | Times Cited: 1
A missense variant effect map for the human tumour suppressor protein CHK2
Marinella Gebbia, Daniel S. Zimmerman, Rosanna Jiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protein-truncating and rare missense variants inATMandCHEK2and associations with cancer in UK Biobank whole-exome sequenced data
Toqir K Mukhtar, Naomi Wilcox, Joe Dennis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Germline Variant Profiling of CHEK2 Sequencing Variants in Breast Cancer Patients
Claire E. McCarthy, Scott Baughan, Hunter Dlugas, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 10-19
Closed Access
The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women
Rachisan Djiake Tihagam, Song Lou, Yuqi Zhao, et al.
EMBO Reports (2024)
Closed Access
The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects
Lucrezia Pilenzi, Federico Anaclerio, Anastasia Dell’Elice, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2327-2327
Open Access
Genetic Predisposition to Male Breast Cancer
Markéta Janatová, Marianna Borecká, Petra Zemánková, et al.
Folia Biologica (2024) Vol. 70, Iss. 5-6, pp. 274-284
Closed Access
Comprehensive analysis of the functional impact of single nucleotide variants of humanCHEK2
Claire E. McCarthy, George S. Brush, Roger Piqué-Regi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium
Markéta Janatová, Štěpán Chvojka, Eva Macháčková, et al.
Klinicka onkologie (2023) Vol. 36, Iss. 6
Open Access | Times Cited: 1
Page 1

Scroll to top